idarubicin has been researched along with Lymphoma in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (16.67) | 18.7374 |
| 1990's | 6 (25.00) | 18.2507 |
| 2000's | 12 (50.00) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cen, J; Li, C; Liu, X; Ma, Y; Mei, K; Qian, L; Shen, J; Wang, Y; Zhao, D | 1 |
| Baldini, L; Balzarotti, M; Bobbio, F; Brandes, AA; Ciceri, F; Corazzelli, G; Ferreri, AJ; Ilariucci, F; Montanari, M; Reni, M; Spina, M; Stelitano, C; Zaja, F | 1 |
| Begovac, J; Boban, A; Civljak, R; Dubravcic, K; Lisic, M; Maretic, T; Radman, I; Zadro, R | 1 |
| Cabanillas, F; Cox, JD; Dabaja, BS; Ha, CS; Kyritsis, AP; Levin, V; McLaughlin, P; Meyers, CA; Preti, HA; Pro, B; Seabrooke, LF; Wilder, RB; Yung, WK | 1 |
| Bolam, S; Child, JA; Davies, JM; Gilson, D; Howard, MR; Jalihal, SS; Mackie, MJ; McVerry, BA; Moreton, P; Morgan, GJ; Parapia, LA; Smith, GM; Williams, AT | 1 |
| Crivellari, D; Lombardi, D; Spazzapan, S; Toffoli, G; Veronesi, A | 1 |
| Cerruti, L; Darcy, PK; Jackson, JT; Jane, SM; Johnstone, RW; Smyth, MJ; Tainton, KM; Tanner, JE | 1 |
| Anghilieri, M; Cairoli, R; Marbello, L; Minola, E; Morra, E; Nosari, A; Ricci, F | 1 |
| Abali, H; Barista, I; Demirkazik, F; Kansu, E; Kars, A; Koc, Y; Oyan, B; Tekin, F; Tekuzman, G; Turker, A; Uner, A | 1 |
| Abali, H; Dizdar, O; Erdem, I; Eren, OO; Erman, M; Karadağ, O; Türker, A; Uluç, K; Yilmaz, A | 1 |
| Adams, DJ; Giles, F; Jacobsen, TF; Myhren, F; Rizzieri, DA; Sandvold, ML | 1 |
| Coonley, CJ; Straus, DJ; Warrell, RP; Young, CW | 1 |
| Broggini, M; Colombo, T; Donelli, MG; Italia, C; Marmonti, L | 1 |
| Cotter, SM; L'Heureux, DA; Moore, AS; Rand, WM; Ruslander, D | 1 |
| Ariyoshi, Y; Ogawa, M | 1 |
| Robak, T | 1 |
| Hegewisch-Becker, S; Hossfeld, DK | 1 |
| Chojnowski, K; Góra-Tybor, J; Robak, T | 1 |
| Benner, EJ; Bishop, MR; Copple, B; Greiner, TC; Iversen, PL; Jackson, JD; Joshi, SS; Mann, SL; Rao, AK; Sharp, JG; Vose, JM | 1 |
| Fukushima, T; Goto, N; Kuraishi, Y; Ogawa, M; Ohno, R; Okabe, KI; Ueda, T; Urabe, A; Yamashita, T | 1 |
| Cersosimo, RJ | 1 |
| Bogdanovski, M; McKenzie, IF; Pietersz, GA; Smyth, MJ | 1 |
| Cox, G; Gillies, H; Harper, P; Johnson, S; Liang, R; Parapia, L; Rogers, H | 1 |
| Eridani, S; Pearson, TC; Singh, AK; Slater, NG | 1 |
5 review(s) available for idarubicin and Lymphoma
| Article | Year |
|---|---|
New oral drugs in older patients: a review of idarubicin in elderly patients.
Topics: Administration, Oral; Antibiotics, Antineoplastic; Breast Neoplasms; Female; Humans; Idarubicin; Leukemia; Lymphoma; Male | 2004 |
[Clinical trials of new antitumor drugs in hematopoietic malignancies].
Topics: Acute Disease; Antineoplastic Agents, Phytogenic; Camptothecin; Clinical Trials as Topic; Doxorubicin; Ethics, Medical; Humans; Idarubicin; Irinotecan; Leukemia; Lymphoma | 1994 |
[Clinical pharmacology of idarubicin].
Topics: Animals; Biological Availability; Breast Neoplasms; Female; Humans; Idarubicin; Leukemia; Lymphoma | 1993 |
The MDR phenotype in hematologic malignancies: prognostic relevance and future perspectives.
Topics: Drug Resistance, Multiple; Forecasting; Gene Expression; Humans; Idarubicin; Leukemia; Lymphoma; Multiple Myeloma; Phenotype; Prognosis | 1996 |
Idarubicin: an anthracycline antineoplastic agent.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Breast Neoplasms; Cytarabine; Drug Labeling; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1992 |
3 trial(s) available for idarubicin and Lymphoma
| Article | Year |
|---|---|
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Bromodeoxyuridine; Central Nervous System Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Infusions, Intravenous; Lymphoma; Male; Methotrexate; Middle Aged; Treatment Outcome | 2003 |
The development of targeted chemotherapy for CNS lymphoma-a pilot study of the IDARAM regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Idarubicin; Lymphoma; Male; Methotrexate; Middle Aged; Pilot Projects; United Kingdom | 2004 |
A pharmacokinetic study of idarubicin in Japanese patients with malignant lymphoma: relationship with leukocytopenia and neutropenia.
Topics: Aged; Antibiotics, Antineoplastic; Area Under Curve; Biotransformation; Daunorubicin; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Idarubicin; Japan; Leukocyte Count; Leukopenia; Lymphoma; Male; Middle Aged; Neutropenia | 2001 |
16 other study(ies) available for idarubicin and Lymphoma
| Article | Year |
|---|---|
Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Cytarabine; Dexamethasone; Female; Humans; Idarubicin; Lymphoma; Male; Methotrexate; Middle Aged; Multimodal Imaging; Neoplasm Staging; Prognosis; Rituximab | 2014 |
MATILDE chemotherapy regimen for primary CNS lymphoma: results at a median follow-up of 12 years.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Idarubicin; Lymphoma; Male; Methotrexate; Remission Induction; Thiotepa; Treatment Outcome | 2014 |
Acute promyelocytic leukemia after whole brain irradiation of primary brain lymphoma in an HIV-infected patient.
Topics: Adult; Anti-Retroviral Agents; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bisexuality; Brain; Brain Neoplasms; HIV Infections; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Lymphoma; Male; Remission Induction; Tretinoin | 2009 |
Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caspases; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Nucleus; Cell Survival; Cytochromes c; DNA Mutational Analysis; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Activation; Green Fluorescent Proteins; Humans; Hydrolysis; Hydroxamic Acids; Idarubicin; Lymphoma; Mitosis; Mutation; Retroviridae; Structure-Activity Relationship; Time Factors; Vincristine | 2004 |
Aggressive systemic mastocytosis mimicking sclerosing cholangitis.
Topics: Abdominal Pain; Adrenal Cortex Hormones; Adult; Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Marrow; Budd-Chiari Syndrome; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Clone Cells; Cytarabine; Diagnosis, Differential; Diarrhea; Fatal Outcome; Female; Flushing; Histamine H1 Antagonists; Humans; Idarubicin; Liver; Lymphoma; Mast Cells; Mastocytosis, Systemic; Mutation, Missense; Point Mutation; Prednisone; Proto-Oncogene Proteins c-kit; Recurrence | 2004 |
IIVP salvage regimen induces high response rates in patients with relapsed lymphoma before autologous stem cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Female; Hodgkin Disease; Humans; Idarubicin; Ifosfamide; Infections; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Salvage Therapy; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome | 2005 |
Posterior leukoencephalopathy after combination chemotherapy in a patient with lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Etoposide; Fatal Outcome; Female; Hemoglobins; Humans; Idarubicin; Ifosfamide; Leukoencephalopathy, Progressive Multifocal; Lymphoma; Magnetic Resonance Imaging | 2005 |
Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Line, Tumor; Cytarabine; Deoxycytidine; Drug Interactions; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Hydrazines; Idarubicin; Irinotecan; Leukemia; Lymphoma; Sulfonamides; Topotecan | 2008 |
Clinical evaluation of 4-demethoxydaunorubicin in patients with advanced malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Humans; Idarubicin; Lymphoma; Middle Aged | 1983 |
Activity and distribution of iv and oral 4-demethoxydaunorubicin in murine experimental tumors.
Topics: Administration, Oral; Animals; Daunorubicin; Doxorubicin; Drug Administration Schedule; Female; Half-Life; Idarubicin; Injections, Intravenous; Kinetics; Lymphoma; Male; Mice; Neoplasm Transplantation; Tissue Distribution | 1984 |
Efficacy of, and toxicoses associated with, oral idarubicin administration in cats with neoplasia.
Topics: Administration, Oral; Animals; Anorexia; Cat Diseases; Cats; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Idarubicin; Leukopenia; Lymphoma; Male; Neoplasms; Vomiting | 1995 |
Cladribine as monotherapy or combined with dexamethasone and idarubicin or mitoxantrone in previously treated patients with low-grade lymphoid malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Dexamethasone; Female; Humans; Idarubicin; Lymphoma; Male; Middle Aged; Mitoxantrone | 2000 |
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells.
Topics: Antibiotics, Antineoplastic; Biological Transport; Cell Division; Cell Survival; DNA Primers; Drug Synergism; Gene Expression Regulation, Neoplastic; Genes, p53; Hematopoietic Stem Cells; Humans; Idarubicin; Kinetics; Lymphoma; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
Antitumor activity of idarubicin-monoclonal antibody conjugates in a disseminated thymic lymphoma model.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Ly; Antigens, Neoplasm; Idarubicin; Immunotherapy; Immunotoxins; Kidney Neoplasms; Lung Neoplasms; Lymphoma; Mice; Neoplasm Metastasis; Survival Analysis; Thymus Neoplasms | 1991 |
Phase II trial of idarubicin in patients with advanced lymphoma.
Topics: Antibiotics, Antineoplastic; Bone Marrow Diseases; Daunorubicin; Drug Evaluation; Heart Diseases; Humans; Idarubicin; Lymphoma | 1988 |
Intravenous and oral demethoxydaunorubicin (NSC 256-439) in the treatment of acute leukemia and lymphoma: a pilot study.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Antineoplastic Agents; Daunorubicin; Female; Humans; Idarubicin; Injections, Intravenous; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Pilot Projects | 1985 |